Purpose: Tendon injury is associated with microtears of collagen fibrils leading to regions of stress deprivation (SD). Increased metalloproteinase expression and activity induced by SD can further degrade the matrix, alter tendon material properties, and lead to catastrophic failure. We have observed topographically distinct changes in MMP & ADAMTS expression in tendon degeneration in vivo. The objective of this study was to determine if this represents inherent regional differences in the response of tenocytes to altered loading. Methods: Ovine infraspinatus tendons were dissected into 4 regions (see figure) . Tendon strips were frozen (ex-vivo), or cultured SD for 1, 5 and 15 days (n=5). Ultimate tensile stress (UTS), strain at failure (ε fail ), and elastic modulus (E) were determined in uniaxial tension (10% strain/second). ADAMTS-and MMP-generated aggrecan neoepitopes (NITEGE and DIPEN) were examined by Western blotting of tendon extracts. Gene expression and glycosaminoglycan (GAG) content were measured ex-vivo and in 1, 5 and 15-day cultures. Results: There was no difference in material properties between regions ex-vivo. Tensile tendon (regions 3&4) contained 47% less GAG than regions near bone (1&2) (p < 0.001). There was no regional difference ex-vivo in expression of ADAMTS-1, -4 or-5 or MMP-1, -2, -3, or -13. Compared with 1&2, MMP-9 & -14 expression was less (46% & 55%) in regions 3&4 and TIMP expression was lower in region 4. Material properties and GAG content were unchanged in any region with 1 and 5 days SD. GAG was reduced only in regions 1&2 (44-48%, p<0.05) with 15 days SD, to be at the same level as 3&4. UTS and E (but not ε fail ) were reduced in all regions after 15 days SD, the effect being most marked in regions 3&4 (p<0.05 for UTS). NITEGE and DIPEN decreased in all regions by 15 days SD. Gene expression changes with SD were similar in direction and magnitude between regions. ADAMTS-1, -4, -5 mRNA increased (10-1000 fold) after 1 day, then returned to ex vivo levels by 15 days, except in region 4 where ADAMTS-5 remained elevated. TIMP-3 mRNA decreased 90% by 1 day, and remained decreased (95%) to day 15. MMP -1, -2, -3, -9, -13, & -14 mRNA increased with SD (20 -20000-fold) in all regions. MMP-mRNAs were all maximal by 5, and for -2, -9, -13 & -14 they remained elevated, while MMP-1, -3 declined at 15 days. TIMP-1 increased 5-10 fold at day 1 and 2-5 fold at day 15. TIMP-2 mRNA decreased 50-90% with 1 day SD and then returned to ex-vivo levels (or higher in region 4). Conclusions: Although there were ex-vivo difference in GAG between regions, this did not equate to different material properties.
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There was no regional difference in ADAMTS expression ex vivo, suggesting this is not regulating lower GAG in tensile tendon. However, lower ex-vivo MMP-9 and -14 in tensile tendon and lower TIMPs in region 4, may suggest basal regional differences in matrix remodeling. MMP, ADAMTS and TIMP expression rapidly became uncoupled by SD in favour of increased matrix turnover in all tendon regions. Changes in material properties with 15 days SD culture could not be explained by altered GAG content nor aggrecan proteolysis by ADAMTS or MMPs. Taken together these data suggest that despite regional differences in tendon composition, the response of tenocytes from all tendon regions to SD is similar. Purpose: The aim of this controlled, prospective, randomized and blinded study was to evaluate the effectiveness of tiludronate, a sulphured bisphosphonate, to limit structural, biochemical and molecular changes in the joint and to preserve the functional ability in an experimental dog model of osteoarthritis (OA). The extent of joint damage and functional impairment is hypothesised to be of less magnitude in dogs with prophylactic tiludronate treatment as compared to OA controls. Methods: Baseline values were established the week preceding surgical sectioning of the right knee cranial cruciate ligament, with eight dogs serving as OA controls and eight others receiving four tiludronate injections (2 mg/kg subcutaneous) at two-week intervals starting the day of surgery until 8 weeks. At baseline, week 4 and week 8, the functional outcome was described using objective gait analysis, locomotor activity recording and video-automated behaviour capture (except week 4 for this evaluation). Functional impairment was assessed using a subjective multiparametric pain scale. Electrodermal activity (EDA) was an indirect quantification of pain. At necropsy (week 8), macroscopic and histomorphological analyses of synovium, cartilage and subchondral bone of the femoral condyles and tibial plateaus were assessed. Immunohistochemistry of cartilage (MMP-1, MMP-13, and ADAMTS-5) and subchondral bone (MMP-13 and cathepsin K) was performed. Synovial fluid was analyzed for biochemical inflammatory (PGE 2 and nitrite/nitrate levels) biomarkers. General linear model for repeated measures and non-parametric Mann-Whitney U-test, when necessary, were performed with an α-threshold of 0.05. Results: A better functional outcome was observed in tiludronatetreated dogs than OA controls. Hence, the gait disability was lower and reached statistical significance at week 8 (p=0.05). The locomotor activity was higher at week 4 (p<0.03). Behaviours of painless condition were observed at week 8 (p<0.03) with the video-capture. One component of the pain scale was improved at week 8 (p<0.05). Finally, the painful condition (EDA) was less pronounced at week 4 (p=0.059).Macroscopically, tiludronate-treated dogs had smaller joint effusion (p<0.05), and both the synovial levels of PGE 2 and nitrite/nitrate were reduced (p<0.05). Histologically, the synovitis score was lower (p<0.01) and a greater surface and thickness of subchondral bone (p<0.01) and calcified cartilage (p<0.02) was observed. Immunohistochemical staining revealed lower MMP-13 and ADAMTS-5 levels (p<0.05) in car-tilage and trends towards lower levels of MMP-1 in cartilage, of MMP-13 in calcified cartilage and of cathepsin-K in subchondral bone. Conclusions: Tiludronate demonstrated that it acts at various components of the joint disease, which is translated in improved histomorphometry, decreased production of catabolic enzymes and synovial anti-inflammatory activity. The functional repercussions were evident with better displacement, lower lameness, gait disability and joint pain perception. Purpose: It is known that mechanical and genetic factors contribute to OA development. Their relative contribution to the initiation and progression of OA, however, is poorly defined. Str/ort mutant mice are recognised to be genetically-prone to spontaneous OA primarily on the tibial plateau. Whether this is due to a greater mechanical predisposition to OA initiation or progression, or both, has not been addressed. We have shown that OA-like lesions can be induced selectively in the lateral femur of normal mice using our newly developed knee joint loading model. Herein, we address the hypothesis that joints which are genetically-susceptible to OA (Str/ort) are less resistant to the initiation of load-induced OA-like lesions. Methods: To address if load-induced lesions (which develop primarily in the femur) are generated at sites of greatest mechanical challenge, we first visualised the position of the femur relative to the tibia, before and during application of 9N loads using microcomputed tomography (μCT) imaging integrated with the loading device. This allowed likely points of contact during loading to be directly visualised. To examine the effect of in vivo loading on lesion development, the right knees of 8 week-old CBA (control, non-OA prone n=9) and Str/ort (n=8) male mice were loaded 3 times/week for 2 weeks, (each episode comprised 40 cycles, 0.1Hz at 9N; De Souza et al, 2005) and mice killed 3 days thereafter. Articular cartilage lesions were scored as described by Chambers et al (2002) in multiple 6μm sections at fixed intervals across the entire joint and within each joint compartment (medial/lateral tibia/femur). In each case, right, loaded knees were compared to contra-lateral left, non-loaded knees by paired ttest. Results: Direct visualisation of Str/ort mouse knee joints by μCT showed marked shift in the position of the femur relative to the tibia during loading. It also revealed that the lateral compartment of the knee would likely experience the most compression. Mechanical loading significantly increased OA score in the entire joint of CBA mice. In agreement with previous studies and with μCT analyses, initiation of these OA-like lesions was localised selectively to the lateral femur; no significant load-induced lesions were found in any of the other compartments in CBA mice. In contrast, such OA-like lesions were not initiated in the lateral femur of loaded Str/ort mouse knee joints. These loaded Str/ort joints, instead only showed significantly more severe lesion progression on the medial tibial plateau. Conclusions: MicroCT imaging showed that loading in our model system likely initiates OA-like lesions at sites of greatest contact (lateral femur) in normal, non OA-prone, CBA mice. Str/ort mouse knee joints, in contrast to our stated hypothesis, are surprisingly more resistant to OA initiation at these sites of greatest mechanical challenge during loading. Str/ort mice, nonetheless, do show an accelerated progression at sites naturally susceptible to OA. These data indicate that the mechanical factors involved in OA lesion initiation and progression may differ. Indeed, OA initiation in genetically-prone mice may not necessarily be a direct result of mechanical loading, whilst progression of OA is.
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BIOMECHANICAL MODELS EXPLAIN INCREASED RISKS FOR KNEE OSTEOARTHRITIS DUE TO OBESITY AND LIMB ALIGNMENT
S. Lancianese, A. Lerner Univ. of Rochester, Rochester, NY Purpose: Obesity is clearly associated with increased risk for incidence of knee OA; however, conflicting results have been reported regarding the importance of other factors such as knee alignment, bone properties and meniscal injuries and their interactions with obesity. These conflicting results may stem from the wide degree of variation in other potentially confounding factors in clinical trials. Computational models offer an advantage in their ability to predict detailed stress and strain patterns within multiple tissues, and also allow greater control over confounding variables. Therefore, our objective was to use finite element (FE) analyses to characterize mechanical factors resulting from increased bodyweight and malalignment and to compare these to the increased risks for onset of knee OA identified by a clinical study. Methods: A 3D FE model of the proximal tibia was built using MR images from a normal weight adult male. Trabecular bone material properties were regionally distributed according MRI-based predictions of bone volume fractions. Tibio-meniscal-femoral pressures were distributed over the tibial cartilage/femoral cartilage contact and meniscal/tibial cartilage contact areas determined from the MR images. We investigated data from the Multicenter Osteoarthritis Study (MOST) that determined the odds of developing OA in subjects who are overweight and/or have a malalignment compared to normal weight subjects with neutral alignment. Subjects were stratified according to BMI and alignment (weight: NW=18.5-24.9, OW=25-29.9, OB=30-34.9, and very OB=35-40; alignment based on mechanical axis: varus, neutral and valgus). OA onset was defined as a radiographic K/L score ≥ 2 at follow-up (baseline score of 0 or 1). We estimated "clinical odds ratios" as (#OA at followup)/(# at baseline) normalized to the NW neutral prevalence, for each subgroup. According to the ISO standard, a load of 3X body weight was applied to the model, varying the magnitude for each case based on the BMI groups reported. Variations in medial/lateral contact force ratios were used to reflect the alignment differences, as these measurements are highly correlated (neutral=71/28, varus=80/20, valgus=35/65). Compressive principal stress and strain values were analyzed in medial and lateral regions of the epiphyseal trabecular bone, just distal to the subchondral bone, as well as in the articular cartilage. Average FE model results within the regions of interest were compared with the reported clinical odds ratios for OA onset, and a power-law regression analysis was performed. Results: Higher stresses and strains are depicted throughout the tibial trabecular bone in the cases of increasing weight or malalignment compared to the normal weight case with a neutral alignment. Significant correlations were determined between the clinical odds ratios and the FE model predictions of bone stress (R2=0.89) and strain (R2=0.93). Significant, though slightly lower, correlations were also identified between cartilage stresses and clinical odds ratios (R2=0.83). Conclusions: Our computational modeling predictions support
